| è´§å· | å“牌 | 产å“åç§° | è§„æ ¼ | 包装ã€å‚è€ƒä»·æ ¼ | |
| A795496 | MACKLIN | 3'-å æ°®-3'-脱氧胸苷 | 10mM in DMSO | 185å…ƒ/1ml; | 咨询 |
储å˜ï¼š-20°C 状æ€ï¼šæ¶²ä½“ |
| A801675 | MACKLIN | 3'-å æ°®-3'-脱氧胸苷 | 99% | 59å…ƒ/1g; 170å…ƒ/5g; 545å…ƒ/25g; 1906å…ƒ/100g; | 咨询 |
储å˜ï¼š-20°C 状æ€ï¼šNA 折射率:47 ° (C=1, H2O) |
| A2052 | TCI | 3'-Azido-3'-deoxythymidine | >98.0%(T) | 610元/1G; 1250元/5G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 纯度/åˆ†æžæ–¹æ³• | >98.0%(T) | | 分åå¼/分åé‡ | C10H13N5O4 = 267.25 | | 外观与形状(20℃) | 固体 | | 储å˜åœ¨æƒ°æ€§æ°”体下 | å˜æ”¾äºŽæƒ°æ€§æ°”ä½“ä¹‹ä¸ | | 应é¿å…的情况 | 湿气 (叿¹¿) | | Reaxys-RN | 3595791 | | PubChem物质ID | 87559740 | | SDBS (AIST Spectral DB) | 51948 | | Merck Index (14) | 10123 | | MDLç¼–å· | MFCD00006536 |
æŠ€æœ¯è§„æ ¼ | Appearance | White to Almost white powder to crystal | | Purity(Neutralization titration) | min. 98.0 % | | Melting point | 122.0 to 126.0 ℃ | | Specific rotation [a]20/D | +43.0 to +51.0 deg(C=1, H2O) |
物性(å‚考值) | 熔点 | 124 ℃ | | 比旋光度 [α]D | 47° (C=1,H2O) | | 水溶性 | 微溶 | | 在水ä¸çš„æº¶è§£åº¦ | 20 g/l 25 ℃ | | 溶解性(坿º¶äºŽ) | 乙醇 |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | ä¿¡å·è¯ | è¦å‘Š | | å±é™©æ€§è¯´æ˜Ž | H303 : åžå’½å¯èƒ½æœ‰å®³ã€‚ H351 : 怀疑致癌。
| | 防范说明 | P501 : 将内装物/容器é€åˆ°æ‰¹å‡†çš„废物处ç†åނ处ç†ã€‚ P202 : 在阅读并明了所有安全措施å‰åˆ‡å‹¿æ¬åŠ¨ã€‚ P201 : 使用å‰å–得专用说明。 P280 : 戴防护手套/穿防护æœ/戴防护眼罩/戴防护é¢å…·ã€‚ P312 : 如感觉ä¸é€‚ï¼Œå‘¼å«æ€¥æ•‘ä¸å¿ƒ/医生。 P405 : å˜æ”¾å¤„é¡»åŠ é”。
|
相关法规 |
| 431574 | J&K | 3'-Azido-3'-deoxythymidine(Zidovudine) | 98% | 170元/250MG; 561元/1G; 1159元/5G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | 熔点 | 113-115 | | MDLç¼–ç | MFCD00006536 | | Beilstein | 3595791 | | Merck | 14,10123 | | å˜å‚¨æ¡ä»¶ | Freezer -20℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | æç¤ºè¯ | Warning | | å±é™©è¯´æ˜Ž | H351 | | 防范说明 | P281 | | WGK | 3 | | RTECS | XP2072000 |
|
| PHR1292 | Supelco | Zidovudine | Pharmaceutical Secondary Standard; Certified Reference Material | 1495.61元/1 G; | 咨询 |
产å“说明 一般æè¿° ç”¨äºŽè´¨é‡æŽ§åˆ¶çš„å·²è®¤è¯çš„è¯ç‰©äºŒçº§æ ‡å‡†ï¼Œä¸ºåˆ¶è¯å®žéªŒå®¤å’Œåˆ¶é€ 商æä¾›äº†è¯å…¸åŸºæœ¬æ ‡å‡†çš„ä¸€ç§æ–¹ä¾¿ä¸”æˆæœ¬æ•ˆç›Šå¥½çš„æ›¿ä»£å“。 é½å¤šå¤«å®š(AZT)是一ç§èƒ¸è…ºå˜§å•¶æ ¸è‹·ç±»ä¼¼ç‰©æŠ—HIVè¯ç‰©ï¼Œå·²çŸ¥å¯é™ä½ŽHIV感染患者的æ»äº¡çŽ‡ã€‚å…¶ä½œç”¨æ–¹å¼æ¶‰åŠåˆ°æŠ‘制病毒逆转录酶的活性并阻æ–HIVçš„å¤åˆ¶ã€‚ ç”¨äºŽè´¨é‡æŽ§åˆ¶çš„ç»è®¤è¯çš„è¯ç‰©äºŒçº§æ ‡å‡†ä¸ºåˆ¶è¯å®žéªŒå®¤å’Œåˆ¶é€ 商æä¾›äº†ä¸€ç§æ–¹ä¾¿ä¸”å…·æœ‰æˆæœ¬æ•ˆç›Šçš„è¯å…¸ä¸»è¦æ ‡å‡†æ›¿ä»£å“。 应用 é½å¤šå¤«å®šå¯ç”¨ä½œè¯ç‰©å‚è€ƒæ ‡å‡†å“,通过色谱和分光光度技术对è¯ç‰©åˆ¶å‰‚ã€ç‰‡å‰‚å’Œè¯ç‰©å‰‚åž‹ä¸çš„分æžç‰©è¿›è¡Œæµ‹å®šã€‚ è¿™äº›äºŒçº§æ ‡å‡†å“æ˜¯åˆæ ¼çš„è®¤è¯æ ‡å‡†ç‰©è´¨(CRM)。它们适用于多ç§åˆ†æžåº”用,包括但ä¸é™äºŽè¯ç‰©é‡Šæ”¾æµ‹è¯•ã€è¯ç‰©çš„定性和定é‡åˆ†æžæ–¹æ³•å¼€å‘ã€é£Ÿå“å’Œé¥®æ–™è´¨é‡æŽ§åˆ¶æ£€æµ‹ä»¥åŠå…¶ä»–æ ¡å‡†éœ€æ±‚ã€‚ 生化/生ç†ä½œç”¨ 对 HIV-1 病毒有效的逆转录酶抑制剂。 分æžè¯´æ˜Ž è¿™äº›äºŒçº§æ ‡å‡†å“å¯è¿½æº¯è‡³USPã€EP(PhEur)å’ŒBPä¸€çº§æ ‡å‡†å“。 其他说明 该认è¯å‚考物质(CRM)æ ¹æ® ISO 17034 å’Œ ISO/IEC 17025 进行生产和认è¯ã€‚所有关于 CRM 的信æ¯éƒ½å¯ä»¥åœ¨åˆ†æžè¯ä¹¦ä¸Šæ‰¾åˆ°ã€‚ 附注 æ¬²æŸ¥çœ‹è¯¥ææ–™çš„分æžè¯ä¹¦ç¤ºä¾‹ï¼Œè¯·åœ¨ä¸‹é¢çš„æ ä½ä¸è¾“å…¥ LRAA0303ã€‚è¿™åªæ˜¯ä¸€ä¸ªç¤ºä¾‹è¯ä¹¦ï¼Œå¯èƒ½ä¸æ˜¯æ‚¨æ”¶åˆ°çš„æ‰¹æ¬¡ã€‚ åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 3595791 | | MDLç¼–å· | MFCD00006536 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329823283 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 300 | | ç‰çº§ | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | mp | 113-115 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | è¯å…¸å¯è¿½æº¯æ€§ | traceable to BP 803 traceable to PhEur Z1900000 traceable to USP 1724500 | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O | | InChI | 1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 | | InChI key | HBOMLICNUCNMMY-XLPZGREQSA-N |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Z1900000 | | Zidovudine | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ 对 HIV-1 病毒有效的逆转录酶抑制剂。 包装 Unit quantity: 60 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. æ³¨æ„ Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 3595791 | | MDLç¼–å· | MFCD00006536 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329831604 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | 113-115 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O | | InChI | 1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 | | InChI key | HBOMLICNUCNMMY-XLPZGREQSA-N |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| A2169 | Sigma-Aldrich | 3′-Azido-3′-deoxythymidine | ≥98% (HPLC) | 1068.12å…ƒ/25 MG; 3314.92å…ƒ/100 MG; 4892.2å…ƒ/250 MG; 14815.4å…ƒ/1 G; | 咨询 |
产å“说明 应用 3′-å æ°®-3′-è„±æ°§èƒ¸è‹·å·²ä½œä¸ºé€†è½¬å½•é…¶æŠ‘åˆ¶å‰‚æŠ‘åˆ¶ç—…æ¯’åŸºå› ç»„æ•´åˆå’Œä½œä¸ºæŠ—èŒå‰‚评估其抗沙门æ°èŒæ´»æ€§ã€‚ 包装 1 g in glass bottle 25 mg in glass insert 100, 250 mg in glass bottle 生化/生ç†ä½œç”¨ å æ°®èƒ¸è‹· (AZT) 是一ç§èƒ¸è‹·ç±»ä¼¼ç‰©ï¼Œæ˜¯ HIV-1 ç—…æ¯’çš„é€†è½¬å½•é…¶æŠ‘åˆ¶å‰‚ã€‚å æ°®èƒ¸è‹·å·²è¢«è¯æ˜Žä¼šé™ä½Ž CRISPR ä»‹å¯¼çš„åŒæºå®šå‘ä¿®å¤ (HDR) 的效率。 对 HIV-1 病毒有效的逆转录酶抑制剂。 特点和优势 è¿™ç§åŒ–åˆç‰©æ˜¯ADMEæ¯’æ€§ç ”ç©¶çš„ç‰¹è‰²äº§å“。点击æ¤å¤„å‘现更多特色ADME毒性产å“。在sigma.com/discover-bsmå¯äº†è§£æ›´å¤šå…³äºŽç”Ÿç‰©æ´»æ€§å°åˆ†åçš„å…¶ä»–ç ”ç©¶é¢†åŸŸã€‚ åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 3595791 | | MDLç¼–å· | MFCD00006536 | | PubChem化å¦ç‰©è´¨ç¼–å· | 24278143 | | NACRES | NA.77 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 200 | | 测定 | ≥98% (HPLC) | | å½¢å¼ | powder | | mp | 113-115 ℃ (lit.) | | 溶解性 | H2O: 50 mg/mL | | web metadata keyword.default | Azidothymidine; AZT; Zidovudine, ZDV; 3′-Azido-3′-Deoxythymidine; 30516-87-1; retroviral; reverse transcriptase inhibitor; genotoxin; TK; AZTTP; AZTMP; mitochondrial dna polymerase; hypermethylation. | | å‚¨å˜æ¸©åº¦ | −20℃ | | SMILES string | CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O | | InChI | 1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 | | InChI key | HBOMLICNUCNMMY-XLPZGREQSA-N | | Gene Information | human ... HIVE1(3095) mouse ... Slc29a1(63959) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 个人防护装备 | Eyeshields, Gloves, type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
|
| Y0002266 | | Zidovudine for system suitability A | CRS, European Pharmacopoeia (EP) Reference Standard | 1341.2元/ ; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha 生化/生ç†ä½œç”¨ 对 HIV-1 病毒有效的逆转录酶抑制剂。 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 3595791 | | MDLç¼–å· | MFCD00006536 |
äº§å“æ€§è´¨ | manufacturer/tradename | EDQM | | mp | 113-115 ℃ (lit.) | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O | | InChI | 1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 | | InChI key | HBOMLICNUCNMMY-XLPZGREQSA-N |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1724500 | USP | Zidovudine | United States Pharmacopeia (USP) Reference Standard | 3231.47元/400 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ 对 HIV-1 病毒有效的逆转录酶抑制剂。 分æžè¯´æ˜Ž These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 3595791 | | MDLç¼–å· | MFCD00006536 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329751524 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | 113-115 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O | | InChI | 1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 | | InChI key | HBOMLICNUCNMMY-XLPZGREQSA-N |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP895 | | Zidovudine impurity standard | British Pharmacopoeia (BP) Reference Standard | 1989元/25 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ 对 HIV-1 病毒有效的逆转录酶抑制剂。 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 3595791 | | MDLç¼–å· | MFCD00006536 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | BP | | mp | 113-115 ℃ (lit.) | | æ ¼å¼ | mixture | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O | | InChI | 1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 | | InChI key | HBOMLICNUCNMMY-XLPZGREQSA-N |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 998003 | Amethyst | 3'-Azido-3'-deoxythymidine | 98%, 试剂级 | 45元/250MG; 98元/1G; 269元/5G; 572元/25G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | 熔点 | 113-115 | | MDLç¼–ç | MFCD00006536 | | Beilstein | 3595791 | | Merck | 14,10123 | | å˜å‚¨æ¡ä»¶ | Freezer -20℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | æç¤ºè¯ | Warning | | å±é™©è¯´æ˜Ž | H351 | | 防范说明 | P281 | | WGK | 3 | | RTECS | XP2072000 |
|
| 358376 | Fluorochem | 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione | = 99% (assay) | 286元/1g; 704元/5g; 1958元/25g; 6160元/100g; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | CAS Number | 30516-87-1 | | MDL Number | MFCD00006536 | | Melting Point | 124℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | å±é™©æ€§è¯´æ˜Ž | H351: Suspected of causing cancer ..
| | 防范说明 | P201: Obtain special instructions before use. P202: Do not handle until all safety precautions have been read and understood. P281: Use personal protective equipment as required. P308 + P313: IF exposed or concerned: Get medical advice/ attention. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|